Title 52, Occupations and Professions

(1) The State Board of Pharmacy shall convene a Public Health and Pharmacy Formulary Advisory Committee consisting of seven members, appointed by the Governor, for the purpose of advising the board in promulgating rules under ORS 689.645. The committee shall consist of: (a) Two p…

A pharmacist may administer a drug or device if the pharmacist is acting: (1) Under the direction of or pursuant to a lawful prescription or order issued by a licensed practitioner acting within the scope of the practitioner’s practice; and (2) In accordance with the rules adopte…

(1) A pharmacy may perform the tests and examinations described in subsection (2) of this section if the pharmacy obtains a waiver from the United States Department of Health and Human Services pursuant to 42 C.F.R. 493.35 and complies with the requirements of 42 C.F.R. 493.35, 4…

(1) Consistent with the protocols adopted by the State Board of Pharmacy by rule, as recommended by the Public Health and Pharmacy Formulary Advisory Committee, a pharmacist may test for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and prescribe, dispense and admi…

(1) In accordance with rules adopted by the State Board of Pharmacy under ORS 689.205, a pharmacist may prescribe and administer injectable hormonal contraceptives and prescribe and dispense self-administered hormonal contraceptives. (2)(a) The board shall adopt rules to establis…

(1) A pharmacist may dispense to a patient, pursuant to a prescription from a practitioner, a prescription drug that is approved by the United States Food and Drug Administration and that contains one or more cannabinoids. (2) The State Board of Pharmacy may adopt rules to carry …

(1) As used in this section: (a) “Insulin” includes various types of insulin analogs and insulin-like medications, regardless of activation period or whether the solution is mixed before or after dispensation. (b) “Insulin-related devices and supplies”: (A) Includes needles, syri…

(1) A pharmacist may prescribe, dispense and administer to a patient medication for the treatment of opioid use disorder in accordance with: (a) A statewide drug therapy management protocol developed, in consultation with a physician with a background in addiction medicine, by th…

(1) As used in this section, “telepharmacy” means the delivery of pharmacy services by a pharmacist, through the use of a variety of electronic and telecommunications technologies, to a patient at a remote location staffed by a pharmacy technician. (2) The pharmacy services for w…

(1) A pharmacist, pharmacy technician or intern, or an individual similarly licensed or otherwise authorized by another state, who is contracted or employed by a pharmacy may access the pharmacy’s electronic database regardless of whether the pharmacist, pharmacy technician or in…

(1) As used in this section, “final verification” means, after prescription information is entered into a pharmacy’s electronic system and reviewed by a pharmacist for accuracy, a physical verification that the drug and drug dosage, device or product selected from a pharmacy’s in…

(1) As used in this section: (a) “HIV test” has the meaning given that term in ORS 433.045. (b) “Post-exposure prophylactic antiretroviral therapy” means a drug or other therapy intended to reduce the likelihood of the acquisition of human immunodeficiency virus following a possi…

As used in ORS 689.770 to 689.780, “the Charitable Prescription Drug Program” means a drug outlet that has: (1) A valid certificate of registration issued by the State Board of Pharmacy; (2) Volunteered to participate in the Charitable Prescription Drug Program; and (3) Been appr…

(1) There is created in the State Board of Pharmacy the Charitable Prescription Drug Program. The purpose of the program is to distribute donated prescription drugs to needy or uninsured individuals. Participation in the program is voluntary. (2) The program may accept and distri…

The State Board of Pharmacy shall adopt rules to carry out ORS 689.770 to 689.780, including but not limited to: (1) Specifying categories of prescription drugs that the Charitable Prescription Drug Program may not distribute under the program; (2) Prescribing the forms described…

The State Board of Pharmacy shall ensure compliance with ORS 689.770 to 689.780 by: (1) Inspecting the Charitable Prescription Drug Program on a regular basis; and (2) Auditing records required to be maintained by a pharmacy in connection with the program. [2009 c.300 §5]

An individual is eligible to obtain donated prescription drugs through the Charitable Prescription Drug Program created in ORS 689.772 if the individual: (1) Is a resident of this state; and (2)(a) Does not have health insurance coverage for the prescription drug requested; (b) I…

(1) As used in this section, “participant” means: (a) A person who donates a prescription drug to the Charitable Prescription Drug Program; (b) The Charitable Prescription Drug Program; (c) The State Board of Pharmacy; (d) A pharmacist; (e) A drug manufacturer; or (f) A health pr…

(1) As used in this section: (a) “Kit” means a package of one or more doses of a short-acting opioid antagonist and the necessary medical supplies to administer the short-acting opioid antagonist. (b) “Opioid” means a natural, synthetic or semisynthetic chemical that interacts wi…

(1) As used in this section: (a) “Opioid” means a natural, synthetic or semisynthetic chemical that interacts with opioid receptors on nerve cells in the body and brain to reduce the intensity of pain signals and feelings of pain. (b) “Opioid overdose” means a medical condition t…

(1) For purposes of this section, “social services agency” includes, but is not limited to, homeless shelters and crisis centers. (2) A person may administer to an individual a short-acting opioid antagonist, as defined in ORS 689.800, that was not distributed to the person if: (…

(1) A retail or hospital outpatient pharmacy shall provide written notice in a conspicuous manner that a short-acting opioid antagonist, as defined in ORS 689.800, and the necessary medical supplies to administer the short-acting opioid antagonist are available at the pharmacy. (…

(1) As used in this section, “opioid,” “opioid overdose” and “short-acting opioid antagonist” have the meanings given those terms in ORS 689.800. (2)(a) The Public Health Officer appointed under ORS 431.045, or a physician licensed under ORS chapter 677 who is employed by the Ore…

(1) As used in this section, “kit,” “opioid,” “opioid overdose” and “short-acting opioid antagonist” have the meanings given those terms in ORS 689.800. (2) The owner of any building or facility to which the public has legal access may have in the building or facility one or more…

(1) A requirement that a health care provider who is authorized to prescribe drugs in this state label a drug dispensed by the health care provider with the information described in subsection (2) of this section does not apply to a drug approved by the United States Food and Dru…

(1) As used in this section: (a) “Covered entity” has the meaning given that term in 42 U.S.C. 256b(a)(4). (b) “Manufacturer” has the meaning given that term in ORS 646A.689. (c) “340B drug” means a drug that has been subject to an offer of a reduced price by a manufacturer pursu…

(1) In addition to any other liability or penalty provided by law, the State Board of Pharmacy may impose a civil penalty for any violation of ORS 689.818. A civil penalty imposed under this section may not exceed $5,000 per day on a manufacturer for each violation. (2) All penal…

(1) In addition to any other liability or penalty provided by law, the State Board of Pharmacy may impose a civil penalty for any violation of the provisions of this chapter or ORS chapter 475 or any rule of the board. A civil penalty imposed under this subsection may not exceed …

(1) In addition to all other penalties provided by law every person who violates ORS 689.515 or any rule adopted thereunder may incur a civil penalty of up to $250 for every such violation. (2) The penalty imposed under this section may be remitted or mitigated upon such terms an…

(1) Violation of any provision of this chapter or of any rule of the State Board of Pharmacy is a misdemeanor. (2) Failure to comply with any notice, citation or subpoena issued by the board under ORS 689.135 is a misdemeanor. Each day during which the violation continues is a se…